‪Amirhossein Modabbernia, MD, PhD, Assistant Professor of Psychiatry‬

Процитировано

	Все	Начиная с 2020 г.
Статистика цитирования	6549	3388
h-индекс	41	29
i10-индекс	68	59

740

370

185

555

20112012201320142015201620172018201920202021202220232024202532 61 191 338 393 432 438 500 589 553 652 690 669 727 78

Общий доступ

Просмотреть все

24 статьи

1 статья

доступно

недоступно

На основе финансирования

Соавторы

Shahin AkhondzadehPsychiatric Research Center, Roozbeh Hospital, Tehran University of Medical Sciences, IranПодтвержден адрес электронной почты в домене neda.net
Shervin Taslimi MD-MPH-FRCSCDivision of Neurosurgery, Queen’s UniversityПодтвержден адрес электронной почты в домене kingstonhsc.ca
Sophia FrangouIcahn School of Medicine at Mount SInaiПодтвержден адрес электронной почты в домене mssm.edu
Abbas TafakhoriIranian Center of Neurological Research, Tehran University of Medical SciencesПодтвержден адрес электронной почты в домене sina.tums.ac.ir
Reza Malekzadeh M.DProfessor of Internal Medicine ,&Gastroenterology Tehran University of Medical Sciences, IranПодтвержден адрес электронной почты в домене tums.ac.ir
Eva VelthorstHead of Scientific ResearchПодтвержден адрес электронной почты в домене ggz-nhn.nl
Vajiheh AghamollaiiAssociate Professor of Neurology Tehran university of medical sciencesПодтвержден адрес электронной почты в домене sina.tums.ac.ir
Mehdi FarokhniaNational Institutes of Health (NIH)Подтвержден адрес электронной почты в домене nih.gov
Mohammad Hossein HarirchianTehran University of Medical Sciences, Iranian Center of Neurological ResearchПодтвержден адрес электронной почты в домене sina.tums.ac.ir
Mohammad Reza Ostovaneh, MD, MPHJohns Hopkins Medical InstitutionsПодтвержден адрес электронной почты в домене jhmi.edu
Sepideh Saroukhani, MD, MS, PhDUniversity of Texas Health Science Center at HoustonПодтвержден адрес электронной почты в домене uth.tmc.edu
Ali GhaleihaProfessor of Psychiatry, Hamadan University of Medical SciencesПодтвержден адрес электронной почты в домене umsha.ac.ir
MohammadReza MohammadiPsychiatry and Psychology Research Center, Roozbeh Hospital, Tehran University of Medical SciencesПодтвержден адрес электронной почты в домене tums.ac.ir
Reza Hosseini, MD, MPHAssistant Professor of Medicine / Medical Director of Occupational Health Center at SUNY UpstateПодтвержден адрес электронной почты в домене yale.edu
mohammad- reza khodaie -ardakaniassociate professor of psychiatry.university of social welfare&rehabilitation sciencesПодтвержден адрес электронной почты в домене uswr.ac.ir
Dorothy GriceProfessor of Psychiatry, Icahn School of Medicine at Mount SinaiПодтвержден адрес электронной почты в домене mssm.edu
Joseph D BuxbaumIcahn School of Medicine at Mount Sinai, New York, NYПодтвержден адрес электронной почты в домене mssm.edu
Elmira HassanzadehMassachusetts General HospitalПодтвержден адрес электронной почты в домене mgh.harvard.edu
Azad MaroufiAssociate Professor of Psychiatry, Kurdistan University of Medical Sciences, Sanandaj,IranПодтвержден адрес электронной почты в домене muk.ac.ir
Abdollah ShafiabadyProfessor of Counseling, Allameh Tabataba'i UniversityПодтвержден адрес электронной почты в домене atu.ac.ir

Amirhossein Modabbernia, MD, PhD, Assistant Professor of Psychiatry

Department of Psychiatry, Mount Sinai School of Medicine

Подтвержден адрес электронной почты в домене mssm.edu

Population Neuroscience Developmental Psychopathology Evidence Synthesis


Название По числу цитат По году По названию	Процитировано Процитировано	Год
Environmental risk factors for autism: an evidence-based review of systematic reviews and meta-analyses A Modabbernia, E Velthorst, A Reichenberg Molecular autism 8, 1-16, 2017	935	2017
Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies A Modabbernia, S Taslimi, E Brietzke, M Ashrafi Biological psychiatry 74 (1), 15-25, 2013	699	2013
Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study SH Abbasi, F Hosseini, A Modabbernia, M Ashrafi, S Akhondzadeh Journal of affective disorders 141 (2-3), 308-314, 2012	376	2012
Laughter yoga versus group exercise program in elderly depressed women: a randomized controlled trial M Shahidi, A Mojtahed, A Modabbernia, M Mojtahed, A Shafiabady, ... International journal of geriatric psychiatry 26 (3), 322-327, 2011	329	2011
Cortical thickness across the lifespan: Data from 17,075 healthy individuals aged 3–90 years S Frangou, A Modabbernia, SCR Williams, E Papachristou, GE Doucet, ... Human brain mapping 43 (1), 431-451, 2022	235	2022
Effect of saffron on fluoxetine-induced sexual impairment in men: randomized double-blind placebo-controlled trial A Modabbernia, H Sohrabi, AA Nasehi, F Raisi, S Saroukhani, A Jamshidi, ... Psychopharmacology 223, 381-388, 2012	215	2012
Natural history of cavernous malformation: systematic review and meta-analysis of 25 studies S Taslimi, A Modabbernia, S Amin-Hanjani, FG Barker, RL Macdonald Neurology 86 (21), 1984-1991, 2016	183	2016
Memantine add-on in moderate to severe obsessive-compulsive disorder: randomized double-blind placebo-controlled study A Ghaleiha, N Entezari, A Modabbernia, B Najand, N Askari, M Tabrizi, ... Journal of psychiatric research 47 (2), 175-180, 2013	182	2013
Saffron for treatment of fluoxetine‐induced sexual dysfunction in women: randomized double‐blind placebo‐controlled study L Kashani, F Raisi, S Saroukhani, H Sohrabi, A Modabbernia, AA Nasehi, ... Human Psychopharmacology: Clinical and Experimental 28 (1), 54-60, 2013	181	2013
Pioglitazone adjunctive therapy for moderate-to-severe major depressive disorder: randomized double-blind placebo-controlled trial K Sepanjnia, A Modabbernia, M Ashrafi, MJ Modabbernia, ... Neuropsychopharmacology 37 (9), 2093-2100, 2012	158	2012
Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial M Asadabadi, MR Mohammadi, A Ghanizadeh, A Modabbernia, M Ashrafi, ... Psychopharmacology 225, 51-59, 2013	144	2013
Subcortical volumes across the lifespan: Data from 18,605 healthy individuals aged 3–90 years D Dima, A Modabbernia, E Papachristou, GE Doucet, I Agartz, M Aghajani, ... Human brain mapping 43 (1), 452-469, 2022	137	2022
Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia: an 8-week, randomized, double-blind, placebo-controlled study A Modabbernia, F Rezaei, B Salehi, M Jafarinia, M Ashrafi, M Tabrizi, ... CNS drugs 27, 57-65, 2013	136	2013
Does pioglitazone improve depression through insulin-sensitization? Results of a randomized double-blind metformin-controlled trial in patients with polycystic ovarian syndrome … L Kashani, T Omidvar, B Farazmand, A Modabbernia, F Ramzanzadeh, ... Psychoneuroendocrinology 38 (6), 767-776, 2013	130	2013
Melatonin for prevention of metabolic side-effects of olanzapine in patients with first-episode schizophrenia: randomized double-blind placebo-controlled study A Modabbernia, P Heidari, R Soleimani, A Sobhani, ZA Roshan, S Taslimi, ... Journal of psychiatric research 53, 133-140, 2014	128	2014
Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania Z Amrollahi, F Rezaei, B Salehi, AH Modabbernia, A Maroufi, ... Journal of affective disorders 129 (1-3), 327-331, 2011	125	2011
Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized double-blind placebo-controlled study MR Khodaie-Ardakani, O Mirshafiee, M Farokhnia, M Tajdini, ... Psychiatry research 215 (3), 540-546, 2014	112	2014
Oral scopolamine augmentation in moderate to severe major depressive disorder: a randomized, double-blind, placebo-controlled study D Khajavi, M Farokhnia, A Modabbernia, M Ashrafi, SH Abbasi, M Tabrizi, ... The Journal of clinical psychiatry 73 (11), 13538, 2012	107	2012
Impaired gas exchange at birth and risk of intellectual disability and autism: a meta-analysis A Modabbernia, J Mollon, P Boffetta, A Reichenberg Journal of autism and developmental disorders 46, 1847-1859, 2016	90	2016
Granisetron adjunct to fluvoxamine for moderate to severe obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled trial N Askari, M Moin, M Sanati, M Tajdini, SMR Hosseini, A Modabbernia, ... CNS drugs 26, 883-892, 2012	81	2012

В данный момент система не может выполнить эту операцию. Повторите попытку позднее.

Статьи 1–20

Ссылок за год

Повторяющиеся цитирования

Объединенные цитирования

СоавторыСоавторы

Подписаться

Процитировано

Соавторы